The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
Vaczy A, Reglodi D, Somoskeoy T, Kovacs K, Lokos E, Szabo E, Tamas A, Atlasz T.
Vaczy A, et al. Among authors: lokos e.
J Mol Neurosci. 2016 Oct;60(2):186-94. doi: 10.1007/s12031-016-0818-4. Epub 2016 Aug 26.
J Mol Neurosci. 2016.
PMID: 27566170
Maxadilan treatment significantly decreased cytokine expression (CINC-1, IL-1alpha, and L-selectin) in ischemia. In summary, our histological and molecular analysis showed that maxadilan, a selective PAC1 receptor agonist, has a protective role in BCCAO-induced retinal deg …
Maxadilan treatment significantly decreased cytokine expression (CINC-1, IL-1alpha, and L-selectin) in ischemia. In summary, our hist …